Evaluation of Predictive Factors for Psoas Tendinitis After First-line Total Hip Arthroplasty

NCT ID: NCT05029648

Last Updated: 2024-07-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1199 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-08-11

Study Completion Date

2024-06-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of predictive factors for psoas tendinitis after first-line total hip arthroplasty.

A single-centre retrospective study of medical data from the medical records of patients undergoing total hip arthroplasty.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

From the medical records of a series of patients operated on for total hip arthroplasty:

Main objective: To assess individual and surgical factors associated with the development of psoas tendinitis.

Secondary objectives:

* To describe the frequency of occurrence of psoas tendinitis
* To describe the outcome of patients who underwent tenotomy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psoas Tendinitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cohort

Simple cohort

Cohort

Intervention Type OTHER

Cohort

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cohort

Cohort

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged 18 years or older, having been informed of the research
* Patient who has had a total hip replacement implanted for at least six months as a first-line treatment
* Patient who has been regularly monitored since the operation and for whom all clinical and radiological data are available during follow-up visits

Exclusion Criteria

* Patient undergoing revision surgery
* Patient who has indicated his opposition to the use of his medical data
* Patient under legal protection, guardianship or curators
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

GCS Ramsay Santé pour l'Enseignement et la Recherche

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nicolas BONIN, MD

Role: PRINCIPAL_INVESTIGATOR

Clinique de la Sauvegarde

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique de la Sauvegarde

Lyon, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

COS-RGDS-2019-12-054

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Total Hip Registry
NCT01133249 UNKNOWN